Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - entecavir (unii: 5968y6h45m) (entecavir anhydrous - unii:nnu2o4609d) - entecavir tablets, usp are indicated for the treatment of chronic hepatitis b virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (alt or ast) or histologically active disease. none. there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to entecavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. prospective pregnancy data from the apr are not sufficient to adequately assess the risk of birth defects, miscarriage or adverse maternal or fetal outcomes. entecavir use during pregnancy has been evaluated in a limited number of individuals reported to the apr and the number of exposures to entecavir is insufficient to make a risk assessment compared to a reference population. the estimated background rate for major birth defects is 2.7% in the u.s

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

rowex ltd - entecavir monohydrate - film-coated tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

rowex ltd - entecavir monohydrate - film-coated tablet - 1 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

teva b.v. - entecavir - tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - entecavir monohydrate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - entecavir monohydrate -

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - entecavir monohydrate - film-coated tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - entecavir monohydrate - film-coated tablet - 1 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous);   - film coated tablet - 0.5 mg - active: entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous)   excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1r-7003 purified water - entecavir is indicated for the treatment of chronic hbv infection in adults with evidence of active liver inflammation.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - entecavir monohydrate 1.06mg equivalent to 1 mg entecavir (anhydrous);   - film coated tablet - 1 mg - active: entecavir monohydrate 1.06mg equivalent to 1 mg entecavir (anhydrous)   excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1r-7003 purified water - entecavir is indicated for the treatment of chronic hbv infection in adults with evidence of active liver inflammation.